Mark A. Mitchell
6Patents
4h-index
19Co-inventors
50Inventor score
Filing activity: Jun 7, 1995 → Nov 3, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5739350A | CC-1065 analogs | Human Necessities | 58 | Expired |
| US5804593A | .alpha.-Amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors | Chemistry; Metallurgy | 37 | Expired |
| US6437177B1 | &agr;-hydroxy, -amino, and halo derivatives of &bgr;-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors | Chemistry; Metallurgy | 30 | Expired |
| US5847148A | Thiadiazole derivatives useful for the treatment of diseases related to connective tissue degradation | Chemistry; Metallurgy | 12 | Expired |
| US5830869A | Thiadiazole amide MMP inhibitors | Human Necessities | 2 | Expired |
| US7026339B2 | Inhibitors of HCV NS5B polymerase | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.